Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 5/20 | 0.72 |
| ▸ | HTR1A | P08908 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | HTR6 | P50406 | 2/20 | 0.67 |
| ▸ | HTR2C | P28335 | 2/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.67 |
| ▸ | MPO | P05164 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | HTR1D | P28221 | 1/20 | 0.67 |
| ▸ | HTR1B | P28222 | 1/20 | 0.67 |
| ▸ | HTR7 | P34969 | 1/20 | 0.67 |
| ▸ | CTSK | P43235 | 1/20 | 0.67 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.67 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | HTR2B | P41595 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29414676 | 1.00 | HTR2A (0.72) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| Ammonia Solution, Strong SCHEMBL28674693 | 0.98 | HTR2A (0.70) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL28315162 | 0.98 | HTR2A (0.70) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL266641 | 0.89 | SLC6A4 (0.68) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL4985934 | 0.87 | HTR2A (0.77) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| Ammonia Solution, Strong SCHEMBL10491416 | 0.87 | SLC6A4 (0.66) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL109955 | 0.87 | SLC6A4 (0.66) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL24961938 | 0.85 | SLC6A4 (0.64) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL8079335 | 0.85 | SLC6A4 (0.64) | HTR2AHTR1ACYP3A4HTR6HTR2C | |
| SCHEMBL1563873 | 0.85 | SLC6A4 (0.64) | HTR2AHTR1ACYP3A4HTR6HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240261419-A1 | PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION (CA) | 2024-08-08 | — | — | US | claimed |
| CN-115956483-A | Method for improving early-maturing property of japonica rice | 许可 | 2023-04-14 | — | — | CN | claimed |
| CN-109715617-B | Dimethoxyphenyl-substituted indole compounds as inhibitors of TLR7, TLR8 or TLR9 | 百时美施贵宝公司 | 2022-04-19 | — | — | CN | claimed |
| CN-110178845-A | A kind of organic RE compound and its preparation method and application that growth-promoting is disease-resistant | 中国农业大学 | 2019-08-30 | — | — | CN | claimed |
| CN-110169495-A | A kind of feed addictive improving intestinal immunity and intestinal growth | 湖南师范大学 | 2019-08-27 | — | — | CN | claimed |
| CN-108770853-A | A kind of plant establishment controlled release long-acting film and preparation method thereof | 高佳喜 | 2018-11-09 | — | — | CN | claimed |
| CN-105073767-B | The propionate of indoles 3 of stable S adenosine L methionine | 赫伯特·山姆-E有限责任公司 | 2018-01-02 | — | — | CN | claimed |
| WO-2017160361-A1 | POLYISOCYANURATE CATALYSTS FOR METAL PANELS AND SPRAY FOAMS | HUNTSMAN PETROCHEMICAL LLC (US) | 2017-09-21 | — | — | WO | claimed |
| CN-107105642-A | Plant growth regulator and the non-aqueous solution of polarity and/or semi-polarity organic solvent | 斯托尔勒企业公司 | 2017-08-29 | — | — | CN | claimed |
| CN-103554170-B | Aryl organic acid ester-containing tricyclohexyltin compounds, and preparation methods and application thereof | 衡阳师范学院 | 2017-02-08 | — | — | CN | claimed |
| WO-1998033776-A1 | COMBINATORIAL LIBRARIES OF HYDANTOIN AND THIOHYDANTOIN DERIVATIVES, METHODS OF MAKING THE LIBRARIES AND COMPOUNDS THEREIN | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| EP-0422178-A1 | PYRIMIDINE DERIVATIVES. | ICI PLC (GB) | 1991-04-17 | — | — | EP | claimed |
| WO-2026106815-A1 | Z-INDUCING CHIMERA COMPOSITION | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2024151855-A1 | BICYCLIC CARBAMOYL PYRIDONE-BASED INTEGRASE STRAND TRANSFER INHIBITORS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-18 | — | — | WO | disclosed |
| US-12037415-B2 | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient | YUYU PHARMA, INC. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-12037415-B2 | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient | YUYU PHARMA, INC. (KR) | 2024-07-16 | — | — | US | disclosed |
| EP-0011277-A1 | Dechloromaytansinoids, their production and use and pharmaceutical compositions containing them | Takeda Chemical Industries, Ltd. (JP) | 1980-05-28 | — | — | EP | disclosed |
| EP-0004466-A1 | Demethyl maytansinoids and methods for producing them | Takeda Chemical Industries, Ltd. (JP) | 1979-10-03 | — | — | EP | disclosed |
| US-4059583-A | CARDIAC RATE LOWERING | MCNEIL LABORATORIES, INCORPORATED (US) | 1977-11-22 | — | — | US | disclosed |
| US-3946009-A | ADRENERGIC BLOCKING AGENTS | MERCK SHARP & DOHME (I.A.) CORPORATION (US) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240261419-A1 | PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES | OPRL1, OPRK1, OPRM1 | HTR2A 9/4885HTR1A 15/4885CYP3A4 2187/4885 |
| US-12037415-B2 | Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient | VIP, IAPP, NGLY1 | HTR2A 4057/4885HTR1A 3988/4885CYP3A4 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.